Adler, Charles H.

MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,653

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 4,383

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 2,609

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 911

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 698

Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease

Weintraub, D., Hoops, S., Shea, J. A., Lyons, K. E., Pahwa, R., Driver‐Dunckley, E. D., Adler, C. H., Potenza, M. N., Miyasaki, J., Siderowf, A. D., et al. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 528

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology

Organ Donation and TransplantationEthics in Clinical Research

Cited by 460

Defining mild cognitive impairment in Parkinson's disease

Caviness, J. N., Driver‐Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., Evidente, V. G. H., Shill, H. A., & Adler, C. H. (2007) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 422

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

Boeve, B. F., Silber, M. H., Ferman, T. J., Lin, S. C., Benarroch, E. E., Schmeichel, A. M., Ahlskog, J. E., Caselli, R. J., Jacobson, S., Sabbagh, M., et al. (2013) · Sleep Medicine

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 393

Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology

Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE

Extracellular vesicles in diseaseMicroRNA in disease regulation

Cited by 385

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

Brin, M. F., Lyons, K. E., Doucette, J., Adler, C. H., Caviness, J. N., Comella, C. L., Dubinsky, R. M., Friedman, J. H., Manyam, B. V., Matsumoto, J. Y., et al. (2001) · Neurology

Botulinum Toxin and Related Neurological DisordersDeep Brain Stimulation and Movement Disorders

Cited by 233

Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

Toledo, J. B., Gopal, P., Raible, K., Irwin, D. J., Brettschneider, J., Sedor, S., Waits, K., Boluda, S., Grossman, M., Van Deerlin, V. M., et al. (2016) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 184

Evaluation of α-synuclein immunohistochemical methods used by invited experts

Beach, T. G., White, C. L., Hamilton, R. L., Duda, J. E., Iwatsubo, T., Dickson, D. W., Leverenz, J. B., Roncaroli, F., Buttini, M., Hladik, C. L., et al. (2008) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 182

Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry

Kellie, J. F., Higgs, R. E., Ryder, J. W., Major, A., Beach, T. G., Adler, C. H., Merchant, K., & Knierman, M. D. (2014) · Scientific Reports

Advanced Proteomics Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 182

Increased CSF biomarkers of angiogenesis in Parkinson disease

Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology

Parkinson's Disease Mechanisms and TreatmentsNeurological Disease Mechanisms and Treatments

Cited by 150

Incidental Lewy body disease: Clinical comparison to a control cohort

Adler, C. H., Connor, D. J., Hentz, J. G., Sabbagh, M. N., Caviness, J. N., Shill, H. A., Noble, B., & Beach, T. G. (2010) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 143

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition

Filon, J. R., Intorcia, A. J., Sue, L. I., Vazquez Arreola, E., Wilson, J., Davis, K. J., Sabbagh, M. N., Belden, C. M., Caselli, R. J., Adler, C. H., et al. (2016) · Journal of Neuropathology & Experimental Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 143

Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 128

The ???Yips??? in Golf: A Continuum Between a Focal Dystonia and Choking

Smith, A. M., Adler, C. H., Crews, D., Wharen, R. E., Laskowski, E. R., Barnes, K., Valone Bell, C., Pelz, D., Brennan, R. D., Smith, J., et al. (2003) · Sports Medicine

Sport Psychology and PerformanceSports Dynamics and Biomechanics

Cited by 112

Spasmodic dysphonia: a review. Part 2: characterization of pathophysiology

Hintze, J. M., Ludlow, C. L., Bansberg, S. F., Adler, C. H., & Lott, D. G. (2017) · Otolaryngology–Head and Neck Surgery

Voice and Speech DisordersDeep Brain Stimulation and Movement Disorders

Cited by 76

The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients

Patel, A. B., Bansberg, S. F., Adler, C. H., Lott, D. G., & Crujido, L. (2015) · Annals of Otology, Rhinology & Laryngology

Voice and Speech DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 60

Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease

Caviness, J. N., Lue, L., Hentz, J. G., Schmitz, C. T., Adler, C. H., Shill, H. A., Sabbagh, M. N., Beach, T. G., & Walker, D. G. (2016) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 37

Altered aiming movements in Parkinson's disease patients and elderly adults as a function of delays in movement onset

Romero, D. H., Van Gemmert, A. W. A., Adler, C. H., Bekkering, H., & Stelmach, G. E. (2003) · Experimental Brain Research

Motor Control and AdaptationParkinson's Disease Mechanisms and Treatments

Cited by 33

Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology

Walker, D. G., Lue, L.-F., Tang, T. M., Adler, C. H., Caviness, J. N., Sabbagh, M. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2017) · Neurobiology of Aging

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 33